Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia.

Amini A, Ghaffari SH, Mortazai Y, Daliri K, Taranejoo S, Alimoghadam K, Ghavamzadeh A.

Mol Biol Rep. 2014 Jul 12. [Epub ahead of print]

PMID:
25015264
[PubMed - as supplied by publisher]
2.

The Beneficial Effects of Valproic Acid in Thyroid Cancer Are Mediated through Promoting Redifferentiation and Reducing Stemness Level: An In Vitro Study.

Haghpanah V, Malehmir M, Larijani B, Ahmadian S, Alimoghaddam K, Heshmat R, Ghavamzadeh A, Adabi K, Ghaffari SH.

J Thyroid Res. 2014;2014:218763. doi: 10.1155/2014/218763. Epub 2014 May 15.

PMID:
24963441
[PubMed]
Free PMC Article
3.

Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma.

Akbari A, Amanpour S, Muhammadnejad S, Ghahremani MH, Ghaffari SH, Dehpour AR, Mobini GR, Shidfar F, Abastabar M, Khoshzaban A, Faghihloo E, Karimi A, Heidari M.

Daru. 2014 Jun 5;22:47. doi: 10.1186/2008-2231-22-47.

PMID:
24902843
[PubMed - in process]
Free PMC Article
4.

Metabolism of arsenic trioxide in acute promyelocytic leukemia cells.

Khaleghian A, Ghaffari SH, Ahmadian S, Alimoghaddam K, Ghavamzadeh A.

J Cell Biochem. 2014 Oct;115(10):1729-39. doi: 10.1002/jcb.24838.

PMID:
24819152
[PubMed - in process]
5.

Silibinin induces apoptosis and inhibits proliferation of estrogen receptor (ER)-negative breast carcinoma cells through suppression of nuclear factor kappa B activation.

Yousefi M, Ghaffari SH, Zekri A, Hassani S, Alimoghaddam K, Ghavamzadeh A.

Arch Iran Med. 2014 May;17(5):366-71. doi: 0141705/AIM.0011.

PMID:
24784867
[PubMed - in process]
Free Article
6.

Differential expression of human homeodomain TGIFLX in brain tumor cell lines.

Raoofian R, Noori-Daloii MR, Saee-Rad S, Modarresi MH, Ghaffari SH, Mojarrad M, Abolhasani F, Heidari M.

Acta Med Iran. 2013;51(12):834-41.

PMID:
24442537
[PubMed - in process]
7.

Differential sensitivity of p44/p42-MAPK- and PI3K/Akt-targeted neuroblastoma subtypes to arsenic trioxide.

Yousefi M, Ghaffari SH, Zekri A, Ghanizadeh-Vesali S, Hosseini E, Rostami M, Hassani S, Alimoghaddam K, Ghavamzadeh A.

Neurochem Int. 2013 Dec;63(8):809-17. doi: 10.1016/j.neuint.2013.10.005. Epub 2013 Oct 23.

PMID:
24161621
[PubMed - indexed for MEDLINE]
8.

Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.

Zekri A, Ghaffari SH, Yousefi M, Ghanizadeh-Vesali S, Mojarrad M, Alimoghaddam K, Ghavamzadeh A.

Mol Cell Endocrinol. 2013 Sep 5;377(1-2):84-92. doi: 10.1016/j.mce.2013.07.002. Epub 2013 Jul 10.

PMID:
23851143
[PubMed - indexed for MEDLINE]
9.

Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells.

Ghasemi R, Ghaffari SH, Momeny M, Pirouzpanah S, Yousefi M, Malehmir M, Alimoghaddam K, Ghavamzadeh A.

Nutr Cancer. 2013;65(4):590-9. doi: 10.1080/01635581.2013.770043.

PMID:
23659451
[PubMed - indexed for MEDLINE]
10.

Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.

Hassani S, Ghaffari SH, Zaker F, Mirzaee R, Mardani H, Bashash D, Zekri A, Yousefi M, Zaghal A, Alimoghaddam K, Ghavamzadeh A.

Ann Hematol. 2013 Sep;92(9):1207-20. doi: 10.1007/s00277-013-1763-8. Epub 2013 May 5.

PMID:
23645216
[PubMed - indexed for MEDLINE]
11.

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Kast RE, Boockvar JA, Brüning A, Cappello F, Chang WW, Cvek B, Dou QP, Duenas-Gonzalez A, Efferth T, Focosi D, Ghaffari SH, Karpel-Massler G, Ketola K, Khoshnevisan A, Keizman D, Magné N, Marosi C, McDonald K, Muñoz M, Paranjpe A, Pourgholami MH, Sardi I, Sella A, Srivenugopal KS, Tuccori M, Wang W, Wirtz CR, Halatsch ME.

Oncotarget. 2013 Apr;4(4):502-30. Review.

PMID:
23594434
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL.

Bashash D, Ghaffari SH, Zaker F, Kazerani M, Hezave K, Hassani S, Rostami M, Alimoghaddam K, Ghavamzadeh A.

Anticancer Agents Med Chem. 2013 Sep;13(7):1115-25.

PMID:
23293885
[PubMed - indexed for MEDLINE]
13.

Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells.

Bashash D, Ghaffari SH, Mirzaee R, Alimoghaddam K, Ghavamzadeh A.

Leuk Lymphoma. 2013 Mar;54(3):561-8. doi: 10.3109/10428194.2012.704034. Epub 2012 Sep 28.

PMID:
22957790
[PubMed - indexed for MEDLINE]
14.

Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription.

Ghaffari SH, Momeny M, Bashash D, Mirzaei R, Ghavamzadeh A, Alimoghaddam K.

Hematology. 2012 Jul;17(4):198-206. doi: 10.1179/1607845412Y.0000000008.

PMID:
22944098
[PubMed - indexed for MEDLINE]
15.

Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-κB expressions may play an important role in silibinin-induced response.

Yousefi M, Ghaffari SH, Soltani BM, Nafissi S, Momeny M, Zekri A, Behmanesh M, Alimoghaddam K, Ghavamzadeh A.

Neurochem Res. 2012 Sep;37(9):2053-63. doi: 10.1007/s11064-012-0827-9. Epub 2012 Jun 21.

PMID:
22717697
[PubMed - indexed for MEDLINE]
16.

Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.

Yaghmaie M, Alimoghaddam K, Mozdarani H, Ghavamzadeh A, Hajhashemi M, Aznab M, Ghaffari SH.

Iran Biomed J. 2012;16(1):10-7.

PMID:
22562027
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis.

Kollaee A, Ghaffarpor M, Ghlichnia HA, Ghaffari SH, Zamani M.

Int J Immunogenet. 2012 Oct;39(5):414-22. doi: 10.1111/j.1744-313X.2012.01104.x. Epub 2012 Mar 9.

PMID:
22404765
[PubMed - indexed for MEDLINE]
18.

Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription.

Bashash D, Ghaffari SH, Zaker F, Hezave K, Kazerani M, Ghavamzadeh A, Alimoghaddam K, Mosavi SA, Gharehbaghian A, Vossough P.

Cancer Invest. 2012 Jan;30(1):57-64. doi: 10.3109/07357907.2011.629378.

PMID:
22236190
[PubMed - indexed for MEDLINE]
19.

Gene amplification and overexpression of Aurora-C in breast and prostate cancer cell lines.

Zekri A, Lesan V, Ghaffari SH, Tabrizi MH, Modarressi MH.

Oncol Res. 2012;20(5-6):241-50.

PMID:
23581231
[PubMed - indexed for MEDLINE]
20.

Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.

Ghaffari SH, Bashash D, Dizaji MZ, Ghavamzadeh A, Alimoghaddam K.

Tumour Biol. 2012 Feb;33(1):157-72. doi: 10.1007/s13277-011-0259-1. Epub 2011 Nov 10.

PMID:
22072212
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk